A drug shortage is a quality failure with a body count.
Live FDA drug shortage data (openFDA), grouped by status, availability, and therapeutic area. The FDA’s own root-cause analysis puts manufacturing and quality problems at the centre of the shortage crisis — which is why SPEQ treats the shortage list as a quality-system signal, not just a supply-chain one.
By initial FDA posting date. openFDA lists active shortages, so older cohorts thin as entries resolve.
The FDA’s 2019 report Drug Shortages: Root Causes and Potential Solutions found the dominant drivers are not scarcity of raw materials but a lack of incentives to produce, and manufacturing/quality problems that force production to stop. Mature quality systems — the difference a QMM assessment measures — are what keep a line running.
| Drug | Company | Therapeutic area | Availability | Status | Posted |
|---|---|---|---|---|---|
| Bumetanide InjectionInjection | MSN Laboratories Private Limited | Cardiovascular | Available | Current | 2017-12-13 |
| Lisdexamfetamine Dimesylate Tablet, ChewableTablet, Chewable | Novadoz Pharmaceuticals LLC | Psychiatry | Available | Current | 2023-07-14 |
| Desflurane Liquid for Inhalation | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | Anesthesia | — | To Be Discontinued | 2026-07-02 |
| Methylphenidate Hydrochloride Tablet, Extended ReleaseTablet | Janssen Pharmaceuticals | Psychiatry | Available | Current | 2023-07-26 |
| Bumetanide InjectionInjection | Sagent Pharmaceuticals | Cardiovascular | Available | Current | 2018-01-31 |
| Dexmedetomidine Hydrochloride InjectionInjection | HQ Specialty Pharma | Anesthesia | Available | Current | 2020-04-10 |
| Methylprednisolone Acetate InjectionInjection | Sagent Pharmaceuticals | Rheumatology | Available | Current | 2021-12-15 |
| Methylphenidate Hydrochloride Tablet, Extended ReleaseTablet | Janssen Pharmaceuticals | Psychiatry | Available | Current | 2023-07-26 |
| Bumetanide InjectionInjection | Mullan Pharmaceutical Inc. | Cardiovascular | Available | Current | 2017-12-13 |
| Ketorolac Tromethamine InjectionInjection | Sagent Pharmaceuticals | Analgesia/Addiction | Available | Current | 2018-03-26 |
| Bumetanide InjectionInjection | Mullan Pharmaceutical Inc. | Cardiovascular | Available | Current | 2017-12-13 |
| Bumetanide InjectionInjection | Sagent Pharmaceuticals | Cardiovascular | Limited | Current | 2018-01-31 |
| Methylphenidate Hydrochloride Tablet, Extended ReleaseTablet | Janssen Pharmaceuticals | Psychiatry | Available | Current | 2023-07-26 |
| Ketorolac Tromethamine InjectionInjection | Sagent Pharmaceuticals | Analgesia/Addiction | Available | Current | 2018-03-26 |
| Methylphenidate Hydrochloride Tablet, Extended ReleaseTablet | Janssen Pharmaceuticals | Psychiatry | Available | Current | 2023-07-26 |
| Clindamycin Phosphate InjectionInjection | Sagent Pharmaceuticals | Anti-Infective | Available | Current | 2023-03-21 |
| Methylprednisolone Acetate InjectionInjection | Sagent Pharmaceuticals | Rheumatology | Unavailable | Current | 2021-12-15 |
| Rocuronium Bromide InjectionInjection | Sagent Pharmaceuticals | Anesthesia | Unavailable | Current | 2023-02-15 |
| Dexmedetomidine Hydrochloride InjectionInjection | HQ Specialty Pharma | Anesthesia | Available | Current | 2020-04-10 |
| Rocuronium Bromide InjectionInjection | Piramal Critical Care Inc. | Anesthesia | Limited | Current | 2023-02-15 |
| Clonazepam TabletTablet | Prinston Pharmaceutical, Inc. | Neurology | Available | Current | 2023-03-10 |
| Clonazepam TabletTablet | Prinston Pharmaceutical, Inc. | Neurology | Available | Current | 2023-03-10 |
| Sterile Water InjectionInjection | Nephron Pharmaceuticals Corporation | Other | Limited | Current | 2021-11-23 |
| Clonazepam TabletTablet | Prinston Pharmaceutical, Inc. | Neurology | Available | Current | 2023-03-10 |
| Midazolam Hydrochloride InjectionInjection | WG Critical Care | Anesthesia | Available | Current | 2020-04-02 |
Data: U.S. FDA openFDA drug/shortages API, which lists activeshortages (Current or To Be Discontinued) — it carries no per-record cause field, so SPEQ makes no root-cause claim on individual drugs; the quality framing above is cited FDA context. openFDA publishes shortage data for drugs only; SPEQ’s cross-industry coverage lives in the recall Explorer(drug, device & food).